The estimated Net Worth of E Dianne Rekow is at least $1.42 Milión dollars as of 12 June 2019. Elizabeth Rekow owns over 3,500 units of Henry Schein stock worth over $890,491 and over the last 10 years he sold HSIC stock worth over $249,130. In addition, he makes $278,200 as Independent Director at Henry Schein.
Elizabeth has made over 1 trades of the Henry Schein stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,500 units of HSIC stock worth $249,130 on 12 June 2019.
The largest trade he's ever made was selling 3,500 units of Henry Schein stock on 12 June 2019 worth over $249,130. On average, Elizabeth trades about 113 units every 0 days since 2014. As of 12 June 2019 he still owns at least 13,281 units of Henry Schein stock.
You can see the complete history of Elizabeth Rekow stock trades at the bottom of the page.
Dr. Elizabeth Diane Rekow serves as Independent Director of the Company. She was Dean of the Dental Institute at King’s College London and Professor of Orthodontics from 2012 through 2016. From 2002 to 2012, Dr. Rekow was a Professor of Orthodontics at New York University (NYU), during which time she was Senior Vice Provost of Engineering Technology at NYU (from 2008 to 2012) and was Provost of Polytechnic Institute of NYU (from 2009 to 2012). Dr. Rekow has been President of both the International Association for Dental Research and the American Association of Dental Research and, from 2000 to 2011, was an American Dental Association Consultant to the Council on Scientific Affairs. In 2012, she was elected to the Faculty of Dental Surgery of the Royal College of Surgeons (England). Dr. Rekow is an internationally known authority on the performance of new materials and products for use in aesthetic and restorative dentistry and was one of the early pioneers in digital dentistry, capitalizing on her engineering education and industry experience. Dr. Rekow’s team has also carried out research into the use of bio-engineered tissue to facilitate bone replacement in people who have been disfigured by disease or developmental defects. Dr. Rekow holds a number of patents in the dental field and is the author of, or contributor to, more than one hundred publications. Dr. Rekow brings to the Company’s Board of Directors extensive experience with dental product development and knowledge of innovative clinical dental practices. Additionally, the Board of Directors values Dr. Rekow’s insights into the needs of future dental practitioners and the global dental industry.
As the Independent Director of Henry Schein, the total compensation of Elizabeth Rekow at Henry Schein is $278,200. There are 18 executives at Henry Schein getting paid more, with Stanley Bergman having the highest compensation of $14,422,900.
Elizabeth Rekow is 75, he's been the Independent Director of Henry Schein since 2014. There are 4 older and 29 younger executives at Henry Schein. The oldest executive at Henry Schein Inc. is Barry Alperin, 79, who is the Independent Director.
E's mailing address filed with the SEC is C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE, NY, 11747.
Over the last 22 years, insiders at Henry Schein have traded over $272,732,340 worth of Henry Schein stock and bought 23,637 units worth $1,414,559 . The most active insiders traders include Stanley M Bergman, Norman S Matthews a Deborah Derby. On average, Henry Schein executives and independent directors trade stock every 21 days with the average trade being worth of $1,074,342. The most recent stock trade was executed by Lorelei Mc Glynn on 6 September 2024, trading 21,035 units of HSIC stock currently worth $1,457,726.
henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice
Henry Schein executives and other stock owners filed with the SEC include: